In summary, CSFs IgG, IgM, and IgA can be used as a routine monitoring indicator for TBM and CM patients and offer valuable references for the differential diagnosis and efficacy evaluation of these diseases. The gene discussed is CD40LG; the disease is cutaneous mastocytosis.